✦ LIBER ✦

Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability

✍ Scribed by Fässler, Alexander; Bold, Guido; Capraro, Hans-Georg; Cozens, Robert; Mestan, Jürgen; Poncioni, Bernard; Rösel, Johannes; Tintelnot-Blomley, Marina; Lang, Marc

Book ID: 127180251
Publisher: American Chemical Society
Year: 1996
Tongue: English
Weight: 387 KB
Volume: 39
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm960022p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Aza-Peptide Analogu

ChemInform Abstract: Aza-Peptide Analogues as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability.

✍ A. FAESSLER; G. BOLD; H.-G. CAPRARO; R. COZENS; J. MESTAN; B. PONCIONI; J. ROESE 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB

Discovery of GS-8374, a potent human imm

Discovery of GS-8374, a potent human immunodeficiency virus type 1 protease inhibitor with a superior resistance profile

✍ He, Gong-Xing; Yang, Zheng-Yu; Williams, Matthew; Callebaut, Christian; Cihlar, 📂 Article 📅 2011 🏛 The Royal Society of Chemistry 🌐 English ⚖ 209 KB

Potent Human Immunodeficiency Virus Type

Potent Human Immunodeficiency Virus Type 1 Protease Inhibitors That Utilize Noncoded d -Amino Acids as P 2 /P 3 Ligands

✍ Jungheim, Louis N.; Shepherd, Timothy A.; Baxter, Angela J.; Burgess, Jeffrey; H 📂 Article 📅 1996 🏛 American Chemical Society 🌐 English ⚖ 475 KB

ChemInform Abstract: Potent Human Immuno

ChemInform Abstract: Potent Human Immunodeficiency Virus Type 1 Protease Inhibitors That Utilize Noncoded D-Amino Acids as P2/P3 Ligands.

✍ L. N. JUNGHEIM; T. A. SHEPHERD; A. J. BAXTER; J. BURGESS; S. D. HATCH; P. LUBBEH 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB

Inhibitors of Human Immunodeficiency Vir

Inhibitors of Human Immunodeficiency Virus Type 1 Protease Containing 2-Aminobenzyl-Substituted 4-Amino-3-hydroxy-5-phenylpentanoic Acid: Synthesis, Activity, and Oral Bioavailability

✍ Lehr, Philipp; Billich, Andreas; Charpiot, Brigitte; Ettmayer, Peter; Scholz, Di 📂 Article 📅 1996 🏛 American Chemical Society 🌐 English ⚖ 233 KB

4 L-735, 524: An orally bioavailable hum

4 L-735, 524: An orally bioavailable human immunodeficiency virus type 1 protease inhibitor: E.A. Emini, J.P. Vacca, B.D. Dorsey, W.A. Schleif, R.B. Levin, S.L. McDaniel, P.L. Darke, J.A. Zugay, J.C. Quintero, O.M. Blahy, E. Roth, V.V. Sardana, A.J. Schlabach, J.H. Condra, L. Gotlib, K. Holloway, J. Lin, J.-W. Chen, D. Ostovic, P.S. Anderson and J.R. Huff. Merck Research Laboratories, West Point, PA 19486 USA. Bristol Myers Squibb Pharmaceutical Research Institute P.P. Box 4000, Princeton, New Jersey 08543 USA †5 Research Parkway Wallingford, Connecticut, 06492, USA

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 62 KB